Skip to main content

Clinical features and outcome of adult T-cell leukemia/lymphoma: University of Miami experience

Adult T-cell leukemia/lymphoma (ATLL) is an aggressive malignancy with a poor prognosis caused by HTLV-I. Miami is proximal to the Caribbean, where HTLV-I is endemic. We have identified at least 140 cases between 1987 and 2013. A total of 108 patients have been analyzed for treatment response, including 51 acute, 50 lymphomatous, 5 chronic (4 unfavorable), and 2 smoldering types. The median overall survival for acute and lymphomatous was 6 and 10 months respectively, and not reached for chronic and smouldering types. Fifty-one patients (33 acute, 11 lymphomatous, 5 chronic, and 2 smouldering) were treated with high-dose AZT/interferon (IFN) as first line therapy. The complete and overall response rates (CR and ORR) for acute/unfavorable chronic vs. lymphomatous types were 27% vs. 9%, and 57% vs. 9% respectively. Three out of 4 (75%) unfavorable chronic type patients responded to AZT/IFN (2 CR, and 1 partial response). Seventy-three patients received chemotherapy at some point during their treatment. The CR rate and ORR for acute/unfavorable chronic vs. lymphomatous-type patients treated with chemotherapy-based regimens were 33 % vs. 17%, and 60% vs. 73% respectively. Five acute type patients who had failed AZT/IFN achieved remission after chemotherapy. By contrast, patients treated with AZT/IFN as second line therapy generally did not respond. Finally, we observed several long-sustained responses in acute and unfavorable chronic subtypes treated with first line AZT/IFN alone translating into a survival benefit. A comprehensive stratified analysis of clinical characteristics, pertinent immunophenotypic markers, and treatment outcome will be presented at the meeting.

Author information



Corresponding author

Correspondence to Juan Carlos Ramos.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pimentel, A., Reis, I., Chapman-Fredricks, J.R. et al. Clinical features and outcome of adult T-cell leukemia/lymphoma: University of Miami experience. Retrovirology 11, O1 (2014).

Download citation


  • Infectious Disease
  • Cancer Research
  • Poor Prognosis
  • Treatment Outcome
  • Partial Response